Fmoc-L-3,4-difluorophenylalanine is a non-natural, fluorinated amino acid derivative. Its structure features an L-configuration α-amino acid backbone protected by a fluorenylmethyloxycarbonyl (Fmoc) group at the N-terminus and a 3,4-difluorophenyl side chain. This compound is a white to off-white crystalline powder. This derivative is a crucial building block in solid-phase peptide synthesis (SPPS), particularly using the Fmoc strategy. The incorporation of fluorine atoms into the phenylalanine side chain significantly alters the peptide's physicochemical properties, such as enhancing metabolic stability, modulating lipophilicity, and influencing its binding affinity to biological targets. It is extensively used in medicinal chemistry and peptide research to develop novel therapeutic peptides, peptidomimetics, and probes with improved pharmacological profiles. As a specialized, non-proteinogenic amino acid, its primary utility is in the research and development of bioactive peptides. It is not a general-purpose synthetic reagent but a targeted intermediate for constructing complex molecules with specific functions, primarily in the life sciences and pharmaceutical sectors.